Glycemic variability:: A hemoglobin A1c-independent risk factor for diabetic complications

被引：364
作者：
Brownlee, M
Hirsch, IB
机构：
[1] Univ Washington, Sch Med, Diabet Care Ctr, Seattle, WA 98105 USA
[2] Albert Einstein Coll Med, JDRF Int Ctr Diabet Complicat Res, Bronx, NY 10467 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 14期
关键词：
D O I：
10.1001/jama.295.14.1707
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1707 / 1708
页数：2
相关论文
共 21 条
[1]  
*AM COLL END, 2002, ENDOCR PRACT S1, V8, P5
[2]  
[Anonymous], 2005, DIABETES CARE, V28, pS4
[3]  
[Anonymous], 1995, DIABETES, V44, P968
[4]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[5]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[6]  
Devaraj S, 2001, CLIN CHEM, V47, P1974
[7]   Thromboxane, prostacyclin and isoprostanes:: therapeutic targets in atherogenesis [J].
Dogné, JM ;
Hanson, J ;
Pratico, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (12) :639-644
[8]  
DU X, 2006, J CLIN INVEST
[9]   What does postprandial hyperglycaemia mean? [J].
Heine, RJ ;
Balkau, B ;
Ceriello, A ;
Del Prato, S ;
Horton, ES ;
Taskinen, MR .
DIABETIC MEDICINE, 2004, 21 (03) :208-213
[10]  
Hirsch Irl B, 2004, Endocr Pract, V10, P67
123